Surely any group running a trial on behalf of a company would return all data and results to said company. It is then up to the company if they decide to just reprint the results without comment or to write their own analysis and interpretation. I would assume that if we are an "anti infective company in the midst of an infective pandemic" or whatever the tag line was then surely we would clearly understand the results we are presenting and how they are presented. If we don't then that is a worry.
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)